WallStSmart

Healthpeak Properties Inc (DOC)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 113% more annual revenue ($6.11B vs $2.87B). DOC leads profitability with a 7.7% profit margin vs 4.3%. VTR appears more attractively valued with a PEG of 1.74. DOC earns a higher WallStSmart Score of 54/100 (C-).

DOC

Buy

54

out of 100

Grade: C-

Growth: 8.0Profit: 4.5Value: 4.7Quality: 4.5
Piotroski: 2/9Altman Z: 0.24

VTR

Buy

51

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 3.3Quality: 4.0
Piotroski: 4/9Altman Z: 0.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DOCUndervalued (+37.5%)

Margin of Safety

+37.5%

Fair Value

$27.14

Current Price

$19.79

$7.35 discount

UndervaluedFair: $27.14Overvalued
VTROvervalued (-9.8%)

Margin of Safety

-9.8%

Fair Value

$77.07

Current Price

$79.09

$2.02 premium

UndervaluedFair: $77.07Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DOC2 strengths · Avg: 9.0/10
EPS GrowthGrowth
363.9%10/10

Earnings expanding 363.9% YoY

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

VTR2 strengths · Avg: 8.0/10
Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.9%8/10

Revenue surging 21.9% year-over-year

Areas to Watch

DOC4 concerns · Avg: 3.0/10
Return on EquityProfitability
2.8%3/10

ROE of 2.8% — below average capital efficiency

Profit MarginProfitability
7.7%3/10

7.7% margin — thin

Debt/EquityHealth
1.373/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.0%3/10

ROE of 2.0% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
153.8x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : DOC

The strongest argument for DOC centers on EPS Growth, Price/Book.

Bull Case : VTR

The strongest argument for VTR centers on Price/Book, Revenue Growth. Revenue growth of 21.9% demonstrates continued momentum.

Bear Case : DOC

The primary concerns for DOC are Return on Equity, Profit Margin, Debt/Equity. A P/E of 64.7x leaves little room for execution misses.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 153.8x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

DOC profiles as a value stock while VTR is a growth play — different risk/reward profiles.

DOC carries more volatility with a beta of 1.03 — expect wider price swings.

VTR is growing revenue faster at 21.9% — sustainability is the question.

DOC generates stronger free cash flow (237M), providing more financial flexibility.

Bottom Line

DOC scores higher overall (54/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Healthpeak Properties Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are rented to physicians, hospitals and healthcare delivery systems.

Visit Website →

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?